SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 216 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 0.76 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $44,000 | +33.3% | 1,838 | 0.0% | 0.01% | +25.0% |
| Q1 2020 | $33,000 | -25.0% | 1,838 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $44,000 | -13.7% | 1,838 | 0.0% | 0.00% | -20.0% |
| Q3 2019 | $51,000 | -92.8% | 1,838 | +5151.4% | 0.01% | – |
| Q2 2016 | $713,000 | +16.1% | 35 | 0.0% | 0.00% | – |
| Q1 2016 | $614,000 | – | 35 | 0.0% | 0.00% | – |
| Q4 2015 | $0 | -100.0% | 35 | 0.0% | 0.00% | – |
| Q3 2015 | $1,000 | – | 35 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 297,500 | $17,478,000 | 3.94% |
| ASHFORD CAPITAL MANAGEMENT INC | 1,124,405 | $36,341,000 | 3.91% |
| ARMISTICE CAPITAL, LLC | 3,100,000 | $100,192,000 | 1.94% |
| S&T BANK/PA | 316,326 | $10,224,000 | 1.54% |
| Bruce & Co., Inc. | 222,105 | $7,178,000 | 1.47% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 379,875 | $12,278,000 | 1.36% |
| RICE HALL JAMES & ASSOCIATES, LLC | 854,949 | $27,632,000 | 1.10% |
| Soleus Capital Management, L.P. | 251,000 | $8,112,000 | 1.05% |
| Parkman Healthcare Partners LLC | 108,954 | $3,521,000 | 1.03% |
| Aristotle Capital Boston, LLC | 1,258,067 | $40,661,000 | 1.03% |